American International Group, Inc. Gelesis Holdings, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.11 - $0.52 $18 - $88	171 Added 2.02%	8,619 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.22 - $0.51 $223 - $517	1,014 Added 13.64%	8,448 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.34 $225 - $3,777	2,819 Added 61.08%	7,434 $8,000
Q2 2022 Aug 12, 2022	BUY	N/A	4,615 New	4,615 $7,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.